there are provided a new dosage regimens for the gamma secretase inhibitor 2 , 2 - dimethyl - n -- 6 - oxo - 6 , 7 - dihydro - 5h - dibenzoazepin - 7 - yl )- n ′-- malonamide which maximizes anti - tumor activity while maintaining acceptable toxicity levels .